Haihong Pu
Harbin Medical University
13 Papers
Haihong Pu is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 6, co-authored 9 publications.
Chat about Author
Papers
Expression of PD-L1 and prognosis in breast cancer: a meta-analysis.
TL;DR: The findings indicate that PD-L1 expression is a promising biomarker for the prognosis of breast cancer, and may be helpful to clinicians aiming to select the appropriate immunotherapy for breast cancer.
An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma.
TL;DR: A prognostic prediction RiskScore model is established based on the expression profiles of 14 immune-related genes, which shows high prediction accuracy and stability in identifying immune features and could provide clinical guidance for the diagnosis and prognosis of different immunophenotypes.
Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
TL;DR: The G6 PD protein could be served as a potential prognostic biomarker for primary breast carcinoma, and overexpression of G6PD protein predicted a high risk of recurrent metastasis and poor PFS during follow-up.
Prognostic significance of PD-L1 expression and 18 F-FDG PET/CT in surgical pulmonary squamous cell carcinoma
TL;DR: The results suggested that high PD-L1 expression levels and a high SUVmax was associated with poor prognosis in surgical pulmonary SCC, and justified exploring the usefulness of the SUVmax as a predictor of PD-1/PD-L 1 inhibitor activity.
Prognostic value of PD-L1 expression in resected lung adenocarcinoma and potential molecular mechanisms.
TL;DR: PD-L1 expression is an important negative prognostic factor in resected ADC, and this finding has important implications for immunotherapy targeting the PD-1/PD- L1 pathway in patients with resecting ADC.